|
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z # |
Voriconazole, CSF
Test Code94692
CPT Codes
80285<br><strong>This test is not available for New York patient testing.</strong>
Preferred Specimen
0.5 mL CSF collected in a sterile screw-cap vial
Minimum Volume
0.2 mL
Transport Temperature
Room temperature
Specimen Stability
Room temperature: 5 days
Refrigerated: 5 days
Frozen: 30 days
Refrigerated: 5 days
Frozen: 30 days
Methodology
Chromatography/Mass Spectrometry
FDA Status
This test was developed and its analytical performance characteristics have been determined by Quest Diagnostics. It has not been cleared or approved by the U.S. Food and Drug Administration. This assay has been validated pursuant to the CLIA regulations and is used for clinical purposes.
Setup Schedule
Set up: Mon-Sat; Report available: 1-2 days
Reference Range
Therapeutic range is not established.
Interpretation of result should include clinical evaluation.
Interpretation of result should include clinical evaluation.
Clinical Significance
The antifungal drug voriconazole is commonly used in the treatment of various types of fungal infections. An increased fungal resistance to similar drugs of greater toxicity has promoted the use of voriconazole in treating infections caused by aspergillus and other fungal species. The chronic nature of fungal infections demands constant monitoring of voriconazole levels within a patient to ensure that adequate therapeutic levels of the drug are administered, absorbed and subsequently excreted.